PATRYS
Live / Registered — Registered — Section 71 accepted (as of 25 Apr 2019)
What this means for you
Registered since 28 Apr 2009. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79046715
- Registration number
- 3612574
- Mark type
- Stylized text
- Filed
- 12 Jun 2007
- Published for opposition
- 10 Feb 2009
- Registered
- 28 Apr 2009
- Attorney of record
- Mainak H. Mehta
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and biotechnological preparations and substances for human medicinal purposes, namely, for the treatment of cancers and autoimmune diseases; [ veterinary preparations and substances for animal medicinal purposes, namely, for the treatment of cancers and autoimmune diseases; ] diagnostic preparations for medical use and reagents for medical use, namely, for diagnosis of human diseases, such as cancer and autoimmune diseases; [ pharmaceutical and biotechnological preparations, namely, antibodies for the treatment of cancers and autoimmune diseases; ] pharmaceutical and biotechnological preparations, namely, antibody fragments and antibody conjugates for the treatment of cancers and autoimmune diseases; [ pharmaceutical and biotechnological preparations for the reconstruction and repair of antibodies for use in the field of cancers and autoimmune diseases; ] monoclonal antibodies for medical and veterinary use, namely, reagents for the diagnosis and prognosis of human and animal diseases, such as cancer and autoimmune diseases; proteins for medical use, namely, for detecting antibodies; clinical medical reagents, namely, reagents for use in the development of monoclonal antibodies; proteins for medical use, namely, for binding antibodies; [ reagents for veterinary use, namely, reagents for the development of monoclonal antibodies; vaccines; vaccines against cancer, viral infection and bacterial infection, vaccines for human use; vaccine adjuvants; ] medical and veterinary diagnostic reagents, namely, reagents for use in tests for the diagnosis and prognosis of human and animal diseases, such as cancer and autoimmune diseases; reagents for research purposes, namely, diagnostic reagents for medical research applications; cells for medical or clinical use, namely, recombinant human protein production cell lines; proteins for medical use in the field of recombinant DNA technology; biological reagents for medical purposes in the field of molecular biology
- Class 042 — Scientific and technological services: Scientific research and development, clinical research and scientific advisory and consultancy services all in relation to antibody production; drug discovery; [ research and development of vaccines, namely, vaccine screening; ] scientific research advisory services relating to diagnostic products for diagnosing cancers and autoimmune diseases; [ diagnostic testing services, namely, providing reagent sample testing and diagnostic services for others in the field of science; ] medical research services; scientific research for medical purposes; pharmaceutical research services; scientific research advisory services comprising the preparation of reports relating to the performance and analysis of research and the outcomes of research in the field of pharmaceuticals and biotechnology; biochemical, chemical, microscopy, spectroscopy, physiological, histological, and electrical analysis of biological tissues for medical research; scientific research and development services for the production of antibodies; scientific research and development services for the discovery and development of proteins that bind to antibodies
Owner
- PATRYS LIMITED, South Melbourne, AU
- PATRYS LIMITED, MELBOURNE VIC 3000, AU
- PATRYS LIMITED, MELBOURNE VIC 3000, AU
- Patrys Pty Ltd, AU
Prosecution history
- 18 Jan 2020 — INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
- 25 Dec 2019 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 25 Apr 2019 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 25 Apr 2019 — REGISTERED-SEC.71 ACCEPTED
- 09 Apr 2019 — TEAS SECTION 71 RECEIVED
- 28 Apr 2018 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 29 Jun 2017 — INTERNATIONAL REGISTRATION RENEWED
- 01 Jul 2016 — NEW REPRESENTATIVE AT IB RECEIVED
- 11 Sept 2015 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 19 Aug 2015 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 19 Aug 2015 — INVALIDATION PROCESSED
- 06 Jul 2015 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 06 Nov 2014 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 06 Nov 2014 — REGISTERED-SEC.71 ACCEPTED
- 01 Oct 2014 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL